Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN

Steffen Fuchs1,2,3,4,5,6, Clara Danßmann7, Filippos Klironomos7

  • 1Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, 13353, Berlin, Germany. steffen.fuchs@charite.de.

PubMed

Insights

MYCN amplification suppresses circular RNA (circRNA) production in neuroblastoma, a pediatric cancer, through DHX9 RNA helicase. This study reveals specific circRNAs, like circARID1A, driving cancer growth.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are regulatory molecules with identified roles in cancer.
  • Mechanisms by which circRNAs modulate gene expression in cancer remain incompletely understood.
  • Neuroblastoma, a pediatric malignancy, presents an opportunity to study circRNA dysregulation.

Purpose of the Study:

  • To investigate circRNA expression patterns in neuroblastoma.
  • To elucidate the role of MYCN amplification in circRNA biogenesis.
  • To identify specific circRNAs contributing to neuroblastoma pathogenesis.

Main Methods:

  • Deep whole-transcriptome sequencing of 104 primary neuroblastomas.
  • Analysis of circRNA expression in relation to MYCN amplification status.
  • Investigation of molecular interactions involving identified circRNAs and RNA-binding proteins.

Main Results:

  • MYCN amplification globally suppresses circRNA biogenesis, dependent on DHX9 RNA helicase.
  • Similar MYCN-driven circRNA suppression observed in medulloblastoma, suggesting a general mechanism.
  • Identified 25 circRNAs specifically upregulated in neuroblastoma, including circARID1A.
  • circARID1A promotes neuroblastoma cell growth and survival via interaction with KHSRP.

Conclusions:

  • MYCN plays a critical role in regulating circRNA expression in cancer.
  • DHX9 is a key mediator of MYCN's effect on circRNA biogenesis.
  • circARID1A is an oncogenic circRNA in neuroblastoma, highlighting specific circRNAs as therapeutic targets.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K